Total Funding
57
50
Total FundingSeries A raised
Growth Score 57 in past quarter
-4 pts
Heat Score 50 in past quarter
-29 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
126765
Alchemedicine is a biotechnology company that conducts internal and joint drug research and discovery programs.
- Keigo Tanaka: Chief Executive Officer, Board Member & Chairman
About the Company
Alchemedicine is a drug research and development company focused on creating new small-molecule therapies using its proprietary synthesis technology. It aims to deliver safer and more effective treatments by improving existing drugs with weak efficacy or strong side effects. The company is committed to bringing pharmaceuticals to market and
contributing to health.
